IP21-21: Long-Term Effectiveness of a New Drug-Device Combination for BPH Treatment: Final Five-Year Results of Optilume BPH in the EVEREST Study
Friday, May 15, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146B
Abstract
See all the content and easy-to-use features by logging in or registering!